Symposium: BTK Treatment: A Matter of Debate
Powered by: Boston Scientific
BTK intervention remains one of the most controversial arenas in endovascular therapy. Despite technological progress, key questions remain unanswered: Are we treating the right vessel? Are we using the right strategy? How much of our practice is evidence-based—and how much is driven by experience?
This symposium will challenge established concepts, confront clinical controversies, and bring leading experts together to debate the future of BTK treatment. Through live polling, interactive case discussions, and audience-driven questions, attendees will be invited to challenge experts, share perspectives, and actively shape the conversation.
-
Who should be treated and when? The Clinical Decision Challenge in BTK Disease
Referent:in: François Saucy (Morges)
-
Preparing for success: What does Optimal Vessel Preparation Really Mean?
Referent:in: Konstantinos Donas (Langen, Deutschland)
-
The Definitive BTK Treatment Debate: Which Strategy Best Supports Limb Salvage?
Referent:in: Stefano Barco (Zürich)
